Finance

Lists
Q3 2026 earnings • released • EPS beat +21.05% • Revenue miss -52.12%
See results
OPK:NASDAQ
OPKO Health Inc
$1.73
-1.14%
(-0.020) 1D
$1.74
+0.58% (+0.0100)
After hours
Closed: Nov 6, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OPK...
Open
$1.77
High
$1.86
Low
$1.71
Mkt. cap
1.28B
Avg. vol.
4.74M
Volume
6.90M
52-wk high
$1.86
52-wk low
$0.98
EPS
-$0.10
Beta
1.52
Shares outstanding
742.51M
No. of employees
2K
Open
$1.77
High
$1.86
Low
$1.71
Mkt. cap
1.28B
Avg. vol.
4.74M
Volume
6.90M
52-wk high
$1.86
52-wk low
$0.98
EPS
-$0.10
Beta
1.52
Shares outstanding
742.51M
No. of employees
2K
News stories
From web sources and news partners
About OPKO Health Inc
CEO-
Employees2.28K
Founded1991
HeadquartersMiami, Florida, United States
SectorHealth Care
IndustryHealth care provider
Websiteopko.com
Analyst ratings
Based on 3 analysts giving stock ratings to OPK in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OPK in the last 3 months.
Highest
Current $1.73
$4.00 (+131.21%)
Average
$3.08 (+78.03%)
Lowest
$2.25 (+30.06%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Tenthoff
Piper Sandler
Buy
Reiterated
$4.00
+131.2%
11/05/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$3.00
+73.4%
11/05/2026
Michael Petusky
Barrington
Buy
Upgraded
$2.25
+30.1%
10/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
$3.00
+73.4%
02/27/2026
Last report
Nov 4, 2026
Fiscal period
Q3 2026
-$0.05 / -$0.06
+21.05%beat
Revenue / Est. (USD)
65.41M / 136.62M
-52.12%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
148.45M
124.20M
163.58M
65.41M
Cost of goods sold
117.20M
107.64M
116.73M
23.35M
Cost of revenue
117.20M
107.64M
116.73M
23.35M
Research and development expenses
-
-
-
32.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55.22M
48.61M
52.92M
24.84M
Operating expense
74.27M
67.57M
71.89M
73.47M
Total operating expenses
191.47M
175.21M
188.62M
96.82M
Operating income
-43.02M
-51.02M
-25.04M
-31.41M
Other non operating income
-354.00K
139.00K
1.63M
4.11M
EBT including unusual items
-46.92M
-60.96M
-13.40M
-42.87M
EBT excluding unusual items
-51.38M
-57.31M
-31.47M
-42.87M
Income tax expense
-15.66M
-6.11M
-4.98M
-7.31M
Effective tax rate
33.38%
10.02%
37.19%
17.05%
Other operating expenses
-
-
-
-
Net income
-31.26M
-54.85M
-8.42M
-53.53M
Net profit margin
-21.06%
-44.16%
-5.14%
-81.84%
Earnings per share
-0.04
-
-0.03
-0.05
Interest and investment income
3.82M
3.01M
3.22M
2.88M
Interest expense
-11.31M
-10.94M
-11.38M
-13.45M
Net interest expenses
-7.49M
-7.93M
-8.16M
-10.57M
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.64M
-28.82M
-2.63M
-8.68M
Gain or loss from assets sale
601.00K
-34.00K
-17.92M
47.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps